Economic Impact

El Khoury AC, Wallace C, Klimack WK, Razavi H. Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas. J Med Econ. 2012;15(5):887-96. doi: 10.3111/13696998.2012.681332. Epub 2012 May 24. PMID: 22458755. Summary Background Globally, hepatitis C virus (HCV) infects ~3% of the population. The objective of this study was to review published work […]

El Khoury AC, Klimack WK, Wallace C, Razavi H. Economic burden of hepatitis C-associated diseases in the United States. J Viral Hepat. 2012 Mar;19(3):153-60. doi: 10.1111/j.1365-2893.2011.01563.x. Epub 2011 Dec 18. PMID: 22329369. Summary There are approximately 100 drugs in development to treat hepatitis C. Over the next decade, a number of new therapies will become […]